Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Robbins Arroyo LLP: Anavex Life Sciences Corp. (AVXL) Misled Shareholders According to a Recently Filed Class Action

Business Wire January 12, 2016

DEADLINE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Anavex Life Sciences Corp and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

Business Wire January 12, 2016

Harwood Feffer LLP Announces Investigation of Anavex Life Sciences Corp.

PR Newswire January 12, 2016

Investor Alert: The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corp. Investors

Business Wire January 12, 2016

Anavex Announces Positive Dose-Response Data for ANAVEX 2-73 in Alzheimer's Disease Patients

GlobeNewswire January 11, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Anavex Life Sciences Corp and Encourages Investors With Losses in Excess of $250,000 to Contact the Firm

Business Wire January 8, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Anavex Life Sciences Corp. and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

GlobeNewswire January 8, 2016

Anavex Issues Statement Addressing Recent Press Releases by Law Firms

GlobeNewswire January 8, 2016

Anavex Life Sciences Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire January 7, 2016

SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation of Claims against Anavex Life Sciences Corp. And Strongly Encourages Investors to Contact the Firm

Business Wire January 7, 2016

Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Anavex Life Sciences Corp. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - AVXL

GlobeNewswire January 6, 2016

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. (AVXL)

GlobeNewswire January 6, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims against Anavex Life Sciences Corp. and Strongly Encourages Investors to Contact the Firm

Business Wire January 6, 2016

Hagens Berman Alerts Investors in Anavex Life Sciences Corp. (NASDAQCM: AVXL) of February 29, 2016 Lead Plaintiff Deadline in Securities Fraud Class Action Related to Stock Promotion

GlobeNewswire January 6, 2016

INVESTOR NOTICE: Goldberg Law PC Files Securities Class Action Lawsuit against Anavex Life Sciences Corp. and Strongly Encourages Investors to Contact the Firm

Business Wire January 5, 2016

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Anavex Life Sciences Corp.

Business Wire January 5, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

GlobeNewswire January 5, 2016

IMPORTANT SHAREHOLDER ALERT: Goldberg Law PC Files Securities Class Action Lawsuit Against Anavex Life Sciences Corp. and Strongly Encourages Investors to Contact the Firm

Business Wire December 31, 2015

Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. and Certain Officers - AVXL

GlobeNewswire December 30, 2015

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Anavex Life Sciences Corp. and Strongly Encourages Investors to Contact the Firm

Business Wire December 29, 2015